The rising complexity of heart disease requires new ways to treat it, including those that combine surgical and catheter-based approaches in the same patient.
Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.
Researchers are collaborating with the NBA to create a new standard in the detection and reduction of cardiac risk among professional basketball athletes.